Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia

被引:0
|
作者
Fava, S [1 ]
Luoni, M [1 ]
Stioui, S [1 ]
机构
[1] LEGNANO GEN HOSP,CYTOGENET LAB,LEGNANO,ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:484 / 484
页数:1
相关论文
共 50 条
  • [31] Immune-mediated complications during interferon alpha therapy in chronic myelogenous leukemia
    Tóthová, E
    Kafková, A
    Stecová, N
    Fricová, M
    Guman, T
    Svorcová, E
    NEOPLASMA, 2002, 49 (02) : 91 - 94
  • [32] Effect of interferon-alpha (IFN-A) therapy on bone marrow (BM) fibrosis in chronic myelogenous leukemia (CML)
    Wilhelm, M
    Ramos, CM
    OBrien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3537 - 3537
  • [33] Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction
    Hochhaus, A
    Lin, F
    Reiter, A
    Skladny, H
    Mason, PJ
    vanRhee, F
    Shepherd, PCA
    Allan, NC
    Hehlmann, R
    Goldman, JM
    Cross, NCP
    BLOOD, 1996, 87 (04) : 1549 - 1555
  • [34] THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON
    FULLE, HH
    DAHMEN, E
    HELLRIEGEL, KP
    ONKOLOGIE, 1988, 11 (04): : 177 - &
  • [35] THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON
    KURZROCK, R
    GUTTERMAN, JU
    KANTARJIAN, H
    TALPAZ, M
    CANCER INVESTIGATION, 1989, 7 (01) : 83 - 91
  • [36] Interferon therapy in chronic myelogenous leukemia
    Guilhot, F
    Roy, L
    Guilhot, J
    Millot, F
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 585 - +
  • [37] HEMOLYTIC-UREMIC SYNDROME IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA
    SCHLAIFER, D
    DUMAZER, P
    SPENATTO, N
    MIGNONCONTE, M
    BROUSSET, P
    LUMBROSO, C
    COOPER, M
    MULLER, C
    HUGUET, F
    ATTAL, M
    LAURENT, G
    PRIS, J
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) : 254 - 255
  • [38] Proposal of a scoring system for responsiveness to interferon-alpha at diagnosis in chronic myelogenous leukemia.
    Dascalescu, CM
    Chomel, JC
    Bouilly, I
    Chauvet, M
    Sotto, MF
    Guilhot, J
    Rivet, J
    Sotto, JJ
    Kitzis, A
    Guilhot, F
    BLOOD, 1997, 90 (10) : 3988 - 3988
  • [39] A potential mechanism for the resistance of interferon-alpha treatment in chronic myelogenous leukemia patients.
    Henderson, Y
    Deisseroth, AB
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A232 - A232
  • [40] Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia
    Tannir, NM
    Talpaz, M
    Ghazal, H
    Proothi, S
    Kantarjian, HM
    LEUKEMIA & LYMPHOMA, 2000, 39 (5-6) : 647 - 650